Objective: To examine the quality of life of adults with congenital heart disease. Design and setting: Observational, cross sectional study conducted at one general hospital in Birmingham, UK. Patients: All 471 patients registered at the adult congenital heart disease clinic were sent the 36 item short form health survey (SF-36) to assess their quality of life. Questionnaires were completed by 276 (58.6%) patients (41.7 % men; median (interquartile range) age 31.0 (26.3–36.0) years, range 16–85 years). Results: Surprisingly, patients deemed surgically cured (for example, atrial septal defect repair) had significantly poorer quality of life in all domains (all p < 0.05), except for pain, than the general popu-lation, as determined from po...
BACKGROUND Measuring quality of life (QOL) is fundamental to understanding the impact of disease and...
Objective The present cross-sectional study investigated quality of life (QOL) in a large cohort of...
Background: As survival improves in the congenital heart disease (CHD) population, health-related qu...
INTRODUCTION: Despite having increased life expectancy, patients with congenital heart disease are s...
AIMS: During the last decade, a paradigm shift has emerged in the measurement of quality of life, fr...
Aims During the last decade, a paradigm shift has emerged in the measurement of quality of life, fro...
BACKGROUND: Due to better early and long-term outcome, the increasing population of grown-ups with c...
Objective The present cross-sectional study investigated quality of life (QOL) in a large cohort of ...
Over the past four decades, the number of papers on quality of life (QoL) in congenital heart diseas...
Quality of life (QOL) is a key outcome in patients with congenital heart disease (CHD) because CHD h...
To examine the impact of previously operated complex congenital heart disease on health related qual...
BACKGROUND: Measuring quality of life (QOL) is fundamental to understanding the impact of disease an...
International audienceBACKGROUND: Progress in the management of complex congenital heart disease (CH...
Objectives: To assess the perception of the quality of life of adolescents and young adults with con...
Background Quality of Life (QoL) is a prognostic factor in heart failure (HF) of patients with acqui...
BACKGROUND Measuring quality of life (QOL) is fundamental to understanding the impact of disease and...
Objective The present cross-sectional study investigated quality of life (QOL) in a large cohort of...
Background: As survival improves in the congenital heart disease (CHD) population, health-related qu...
INTRODUCTION: Despite having increased life expectancy, patients with congenital heart disease are s...
AIMS: During the last decade, a paradigm shift has emerged in the measurement of quality of life, fr...
Aims During the last decade, a paradigm shift has emerged in the measurement of quality of life, fro...
BACKGROUND: Due to better early and long-term outcome, the increasing population of grown-ups with c...
Objective The present cross-sectional study investigated quality of life (QOL) in a large cohort of ...
Over the past four decades, the number of papers on quality of life (QoL) in congenital heart diseas...
Quality of life (QOL) is a key outcome in patients with congenital heart disease (CHD) because CHD h...
To examine the impact of previously operated complex congenital heart disease on health related qual...
BACKGROUND: Measuring quality of life (QOL) is fundamental to understanding the impact of disease an...
International audienceBACKGROUND: Progress in the management of complex congenital heart disease (CH...
Objectives: To assess the perception of the quality of life of adolescents and young adults with con...
Background Quality of Life (QoL) is a prognostic factor in heart failure (HF) of patients with acqui...
BACKGROUND Measuring quality of life (QOL) is fundamental to understanding the impact of disease and...
Objective The present cross-sectional study investigated quality of life (QOL) in a large cohort of...
Background: As survival improves in the congenital heart disease (CHD) population, health-related qu...